Ronan Kelly
Retired 2020
Pneumonia, diarrhoea kill 400,000 children in India annually
All India | Indo-Asian News Service | Updated: November 13, 2013 00:35 IST
New Delhi: India continues to lose more than 400,000 children before their fifth birthday due to two easily preventable diseases - pneumonia and diarrhoea - according to a new report released on Tuesday.
Many Indian children do not have access to life saving treatment and preventive measures, says the Pneumonia and Diarrhoea Progress Report 2013 published by the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health in Baltimore, US.
The report said India continues to have the largest number of pneumonia and diarrhoea cases in the world.
...
http://www.ndtv.com/article/india/pneumonia-diarrhoea-kill-400-000-children-in-india-annually-445279
Pneumonia and
Diarrhea Progress Report 2013
International Vaccine
Access Center (IVAC)
November 2013
http://www.jhsph.edu/research/cente...C-2013-Pneumonia-Diarrhea-Progress-Report.pdf
...
INDIA?S CONTINUED COMMITMENT TO PROTECTING CHILDREN FROM PNEUMONIA
AND DIARRHEA THROUGH VACCINATIONS
After coming together with the governments of Ethiopia and the United States, along with UNICEF in 2012 to launch a global effort
called ?Committing to Child Survival: A Promise Renewed?, India reaffirmed its commitment to child survival at a national event,
?India?s Call to Action Summit for Child Survival and Development? in February 2013. In addition to the high burden of neonatal health
problems, pneumonia and diarrhea were clearly identified as diseases that must be addressed in order to meet national and international
goals for reducing child deaths and improving wellbeing and quality of life for India?s children.
One key priority coming out of the child survival event was vaccination ? including improvements in routine immunization and introduction
of new vaccines. India made progress on several vaccine efforts this year. Namely, the Hib-containing pentavalent vaccine,
which protects children from one of the leading causes of pneumonia, has now been introduced in 8 states and Delhi.4 Based on
successes in early adopter states, the government of India recently announced plans to roll out pentavalent vaccine nationally.4 Dr.
Jacob John, infectious disease expert and former professor at Christian Median College in Vellore shares his enthusiasm about the
positive news. ?Pneumonia is one of the leading causes of deaths in children below the age of five years. Availability of the pentavalent
vaccine through the universal immunization programme will help not only prevent morbidity associated with pneumonia and meningitis,
but also avert thousands of deaths annually.?
At the same time, a recently developed Indian vaccine is showing promise for protecting children from the leading cause of severe
diarrhea ? rotavirus. This indigenous Indian vaccine, developed through a unique partnership between the government of India and
Bharat Biotech, as well as several international partners, successfully completed phase III trials this spring. It demonstrated 56%
efficacy in the first year of life against severe rotavirus diarrheal disease, as well as a good safety profile. The vaccine is now being
reviewed for licensure and, pending licensure, will be considered by the National Technical Advisory Group on Immunization (NTAGI)
for addition to India?s Universal Immunization Programme (UIP). If introduced into the UIP, the rotavirus vaccine will be a cost-effective
intervention to reduce the toll that severe diarrhea takes on India?s children and families.
This progress in vaccination must be combined with efforts to increase access to treatment and improve coverage rates of other
protective interventions, such as breastfeeding and sanitation, in order to protect all Indian children.
...
All India | Indo-Asian News Service | Updated: November 13, 2013 00:35 IST
New Delhi: India continues to lose more than 400,000 children before their fifth birthday due to two easily preventable diseases - pneumonia and diarrhoea - according to a new report released on Tuesday.
Many Indian children do not have access to life saving treatment and preventive measures, says the Pneumonia and Diarrhoea Progress Report 2013 published by the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health in Baltimore, US.
The report said India continues to have the largest number of pneumonia and diarrhoea cases in the world.
...
http://www.ndtv.com/article/india/pneumonia-diarrhoea-kill-400-000-children-in-india-annually-445279
Pneumonia and
Diarrhea Progress Report 2013
International Vaccine
Access Center (IVAC)
November 2013
http://www.jhsph.edu/research/cente...C-2013-Pneumonia-Diarrhea-Progress-Report.pdf
...
INDIA?S CONTINUED COMMITMENT TO PROTECTING CHILDREN FROM PNEUMONIA
AND DIARRHEA THROUGH VACCINATIONS
After coming together with the governments of Ethiopia and the United States, along with UNICEF in 2012 to launch a global effort
called ?Committing to Child Survival: A Promise Renewed?, India reaffirmed its commitment to child survival at a national event,
?India?s Call to Action Summit for Child Survival and Development? in February 2013. In addition to the high burden of neonatal health
problems, pneumonia and diarrhea were clearly identified as diseases that must be addressed in order to meet national and international
goals for reducing child deaths and improving wellbeing and quality of life for India?s children.
One key priority coming out of the child survival event was vaccination ? including improvements in routine immunization and introduction
of new vaccines. India made progress on several vaccine efforts this year. Namely, the Hib-containing pentavalent vaccine,
which protects children from one of the leading causes of pneumonia, has now been introduced in 8 states and Delhi.4 Based on
successes in early adopter states, the government of India recently announced plans to roll out pentavalent vaccine nationally.4 Dr.
Jacob John, infectious disease expert and former professor at Christian Median College in Vellore shares his enthusiasm about the
positive news. ?Pneumonia is one of the leading causes of deaths in children below the age of five years. Availability of the pentavalent
vaccine through the universal immunization programme will help not only prevent morbidity associated with pneumonia and meningitis,
but also avert thousands of deaths annually.?
At the same time, a recently developed Indian vaccine is showing promise for protecting children from the leading cause of severe
diarrhea ? rotavirus. This indigenous Indian vaccine, developed through a unique partnership between the government of India and
Bharat Biotech, as well as several international partners, successfully completed phase III trials this spring. It demonstrated 56%
efficacy in the first year of life against severe rotavirus diarrheal disease, as well as a good safety profile. The vaccine is now being
reviewed for licensure and, pending licensure, will be considered by the National Technical Advisory Group on Immunization (NTAGI)
for addition to India?s Universal Immunization Programme (UIP). If introduced into the UIP, the rotavirus vaccine will be a cost-effective
intervention to reduce the toll that severe diarrhea takes on India?s children and families.
This progress in vaccination must be combined with efforts to increase access to treatment and improve coverage rates of other
protective interventions, such as breastfeeding and sanitation, in order to protect all Indian children.
...